Penetration by a Giant Gastric Ulcer Induced by a Nonsteroidal Anti-Inflammatory Drug

A patient presented with penetration by a giant gastric ulcer resulting from treatment with a nonsteroidal anti-inflammatory drug. A test for Helicobacter pylori proved negative. Treatment with a combination of an inhibitor of gastric acid secretion and prostaglandin substitution therapy with misoprostol resulted in closure of the perforation and cicatrization of the gastric ulcer without the need for laparotomy.

References

• 1 Vane J R. Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.  Nature. 1971;  231 232-235
• 2 Caruso I, Bianchi P G. Gastroscopic evaluation of anti-inflammatory agents.  Br Med J. 1980;  290 75-78
• 3 The Committee on Safety of Medications. Non-steroidal anti-inflammatory drugs and serious gastrointestinal adverse reactions - 2.  Br Med J. 1986;  292 1190-1191
• 4 Lanza F L. NSAIDs and the gastrointestinal tract.  Abdom Imaging. 1997;  22 1-4
• 5 MacDonald T M, Morant S V, Robinson G C, et al. Association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure: cohort study.  Br Med J. 1997;  315 1333-1337
• 6 Lanas A, Serrano P, Bajador E, et al. Evidence of aspirin use in both upper and lower gastrointestinal perforation.  Gastroenterology. 1997;  112 683-689
• 7 Shiokawa Y, Nobenaga T, Saito T, et al. Epidemiological survey on association of upper gastrointestinal toxicity of non-steroidal anti-inflammatory drugs with continued exposure in Japan.  Rhyumachi (in Japanese). 1991;  31 96-111
• 8 Graham D Y, Agrawal N M, Roth S H, et al. Duodenal and gastric ulcer prevention with misoprostol in arthritis patients taking NSAIDs.  Ann Intern Med. 1993;  119 257-262
• 9 Koch M, Capurso L, Dezi A, et al. Prevention of NSAID-induced gastroduodenal mucosal injury: meta-analysis of clinical trials with misoprostol and H₂-receptor antagonists.  Dig Dis Sci. 1995;  13 (Suppl 1) 62-74